Johnny Ludvigsson, M erectile dysfunction pills .D., Ph.D., David Krisky, M.D., Ph.D., Rosaura Casas, Ph.D., Tadej Battelino, M.D., Ph.D.D., Ph.D., James Greening, M.D., Olga Kordonouri, M.D., Timo Otonkoski, M.D., Ph.D., Paolo Pozzilli, M.D., Jean-Jacques Robert, M.D., Ph.D., Henk J. Veeze, M.D., Ph.D., and Jerry Palmer, M.D.: GAD65 Antigen Therapy in Diagnosed Type 1 Diabetes Mellitus Recently The clinical onset of type 1 diabetes is manifested by the effects of inadequate insulin secretion due to the immunologic destruction of pancreatic-islet beta cells.1 Despite replacement therapy with exogenous insulin, type 1 diabetes is connected with considerable morbidity and mortality.2,3 Even modest preservation of insulin secretion appears to reduce short – and long-term complications of type 1 diabetes.4-9 Initial attempts at immunosuppression to take care of type 1 diabetes had a positive effect but one that was outweighed by treatment-related adverse events.10-12 More recently, selective immunosuppression provides been attempted.
Although industry influence is indisputable, this description conflicts with the impression I got from Judy Faulkner, chief executive officer of EHR maker Epic Systems, who advocates for government-created specifications. Whether other vendors are willing to make their products interoperable, government frequently overrides industry’s financial interests to achieve a larger public good. I’m all for people with vision problems. But now I must put my most skilled staff upon this problem also before sorting out the fundamentals of transmitting information. In our iPhone-reverent age group, the dismissal of EHR critics as Luddites is usually supported by the reputation that technologies we once couldn’t imagine we have now can’t live without.